Current Trends in Telemedicine for Retinopathy of Prematurity
Ru-ik Chee, SAMIR N. PATEL, Karyn E. Jonas, Mrinali Patel Gupta, J Peter Campbell, Michael F. Chiang, R V Paul Chan
Abstract
Ru-ik Chee, SAMIR N. PATEL, Karyn E. Jonas, Mrinali Patel Gupta, J Peter Campbell, Michael F. Chiang, R V Paul Chan
Abstract
Retinopathy of Prematurity (ROP) is a vasoproliferative disease of the retina in premature infants that can progress to blindness. Clinical ROP management standards have been established by seminal studies such as the Cryotherapy for ROP (CRYO-ROP) and Early Treatment for ROP (ET-ROP) trials, and have significantly decreased the incidence of poor visual outcomes in ROP. However, ROP continues to be a leading cause of childhood blindness worldwide.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Retinopathy of Prematurity (ROP) is a vasoproliferative disease of the retina in premature infants that can progress to blindness. Clinical ROP management standards have been established by seminal studies such as the Cryotherapy for ROP (CRYO-ROP) and Early Treatment for ROP (ET-ROP) trials, and have significantly decreased the incidence of poor visual outcomes in ROP. However, ROP continues to be a leading cause of childhood blindness worldwide.
Key concepts: Retinopathy of prematurity, Telemedicine, Medicine, Optometry, Current (fluid), Ophthalmology, Political science, Pregnancy